| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Ackermann Michael is a Director at TARS. Recent filings cover 1 purchase and 16 sales.
Our model assigns Ackermann Michael a strong insider score of 76/100, based on 10 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +32.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2022 | TARS Tarsus Pharmaceuticals, Inc. | Director | Buy | 100,000 | $13.50 | $1,350,000.00 | New | +42.7% | +27.4% | |
| Dec 1, 2021 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 5,833 | $24.68 | $143,934.45 | -0.5% | -21.4% | -30.4% | |
| Nov 1, 2021 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 5,833 | $27.82 | $162,289.06 | -0.5% | -29.0% | -36.6% | |
| Oct 12, 2021 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 5,633 | $26.27 | $147,999.61 | -0.5% | -17.3% | -39.1% | |
| Oct 8, 2021 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 200 | $25.03 | $5,006.00 | - | -7.0% | -32.2% | |
| Sep 1, 2021 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 5,833 | $25.24 | $147,236.59 | -0.5% | +4.3% | -39.9% | |
| Aug 11, 2021 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 621 | $25.15 | $15,619.39 | - | +10.1% | -30.9% | |
| Aug 9, 2021 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 3,829 | $25.00 | $95,725.00 | -0.3% | +14.8% | -27.8% | |
| Aug 5, 2021 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 1,383 | $25.00 | $34,576.50 | -0.1% | +11.1% | -31.5% |